Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease dementia
Phenotype C0030567|parkinson disease
Sentences 29
PubMedID- 23996276 A quantitative study of alpha-synuclein pathology in fifteen cases of dementia associated with parkinson disease.
PubMedID- 25730300 Episodic memory in alzheimer disease, frontotemporal dementia, and dementia with lewy bodies/parkinson disease dementia: disentangling retrieval from consolidation.
PubMedID- 22414859 We investigated thalamic cholinergic afferent integrity by measuring ppn-thalamic (ppn-thal) acetylcholinesterase (ache) activity via pet imaging in alzheimer (ad), parkinson disease without dementia (pd), parkinson disease with dementia (pdd) and dementia with lewy bodies (dlb).
PubMedID- 22829268 This difference was larger than that reported in other studies of cheis in dlb, ad, and parkinson disease with dementia (pdd).15, 32, 33 improvement was also noted in the attentive-executive domains.
PubMedID- 24748671 Csf abeta42 predicts early-onset dementia in parkinson disease.
PubMedID- 25717349 To distinguish dlb from parkinson disease associated with dementia, we excluded patients in whom cognitive impairment had occurred more than 2 years after they were diagnosed with the extrapyramidal syndrome.
PubMedID- 23172764 We compared caregiver burden in parkinson disease with dementia (pdd) to that in alzheimer disease (ad) and examined the factors contributing to the burden in pdd.
PubMedID- 21403021 Background: dementia in parkinson disease (pd) causes nursing home placement, caregiver distress, higher health care burden, and increased mortality.
PubMedID- 19733364 The epidemiology of dementia associated with parkinson disease.
PubMedID- 24058569 Mmse = mini-mental state examination, inph = idiopathic normal pressure hydrocephalus, nc = normal control, pdd = parkinson disease with dementia, dlb = dementia with lewy bodies, psp = progressive supranuclear palsy, ad = alzheimer disease, amyloid(1-42) = amyloid beta peptide 1-42, p-tau = phosphorylated tau, tau = total tau.
PubMedID- 24915072 Diagnosis was: parkinson disease with dementia, multiple system atrophy parkinsonian type, multiple system atrophy cerebellar type, progressive sopranuclear palsy, cortico-basal degeneration, lewy body dementia and fronto-temporal dementia with parkinsonism.
PubMedID- 19948198 Objective: to evaluate the efficacy and safety of yokukansan, a traditional chinese herbal medicine, for treating behavioral and psychological symptoms of dementia (bpsd) in patients with parkinson disease (pd; n=7) and those with pd with dementia (pdd; n=7).
PubMedID- 21977026 For several mainly logistic reasons (e.g., not being able to sit upright for vfs, too weak condition for repeated transport to the outpatient clinic for dysphagia, suffering from parkinson dementia), patients with severe parkinson disease who are often admitted to nursing homes did not find easy access to this study.
PubMedID- 25171928 Predictors of dementia in parkinson disease: a prospective cohort study.
PubMedID- 22354157 An fp-cit pet comparison of the differences in dopaminergic neuronal loss between idiopathic parkinson disease with dementia and without dementia.
PubMedID- 24621278 A meta-analysis showed that apoe ϵ4 allele appeared to be associated with a higher prevalence of dementia in parkinson disease [44].
PubMedID- 20338799 Biomarkers: parkinson disease with dementia and dementia with lewy bodies.
PubMedID- 23890957 Objective: rapid eye movement (rem) sleep behavior disorder (rbd) is a risk factor for dementia in parkinson disease (pd) patients.
PubMedID- 25761375 [20]—parkinson disease patients with dementia and visual hallucinations (n = 7) compared to those without hallucinations (n = 8).
PubMedID- 22461936 During the physical examination we learned that the patient also suffered from parkinson disease complicated by dementia, so her husband became our primary historian.
PubMedID- 26106326 Sunwoo and colleagues concluded that pod clinical characteristics are analogous to the core features of α- as dementia with lewy bodies, parkinson disease dementia; patients experience altered sleep-wake cycles, visual hallucinations, disorganized thinking and attention impairment (sunwoo et al., 2013).
PubMedID- 25745616 Although individual reports often include only small-to-modest subject numbers, there is overall suggestion that pd patients have a lower incidence of abeta-amyloid deposition than seen amongst elderly normal subjects, and that parkinson disease with dementia patients have a lower incidence of abeta-amyloid deposition than do patients with dementia with lewy bodies.
PubMedID- 24495708 Background: prevalence of mild cognitive impairment (mci) and dementia in parkinson disease (pd) is variable because different classification criteria are applied and there is lack of consensus about neuropsychological tests and cut-off used for cognitive profiling.
PubMedID- 23720572 Despite the wide use of clock drawing tests (cdts) for screening cognitive impairment, their use in patients having parkinson disease (pd) with dementia has not been systematically investigated until date.
PubMedID- 20181924 Objective: although parkinson disease with dementia (pdd) and dementia with lewy bodies (dlb) show a wide clinical and neuropathologic overlap, they are differentiated according to the order and latency of cognitive and motor symptom appearance.
PubMedID- 21633129 Seize the day: quantitative eeg as a biomarker for dementia in parkinson disease.
PubMedID- 25802273 Predictors of dementia in parkinson disease: a prospective cohort study.
PubMedID- 21633128 Objective: we evaluated quantitative eeg (qeeg) measures as predictive biomarkers for the development of dementia in parkinson disease (pd).
PubMedID- 22825369 Objective: to determine the relative contributions of individual pathologic protein deposits associated with dementia in patients with parkinson disease (pd).

Page: 1